TY - JOUR
T1 - A world-wide study on delirium assessments and presence of protocols
AU - the WDAD Study Group
AU - on behalf of the WDAD Study Group
AU - Nydahl, Peter
AU - Liu, Keibun
AU - Bellelli, Giuseppe
AU - Benbenishty, Julie
AU - Van Den Boogaard, Mark
AU - Caplan, Gideon
AU - Chung, Chi Ryang
AU - Elhadi, Muhammed
AU - Gurjar, Mohan
AU - Heras-La Calle, Gabi
AU - Hoffmann, Magdalena
AU - Jeitziner, Marie Madlen
AU - Krewulak, Karla
AU - Mailhot, Tanya
AU - Morandi, Alessandro
AU - Nawa, Ricardo Kenji
AU - Oh, Esther S.
AU - Collet, Marie O.
AU - Paulino, Maria Carolina
AU - Lindroth, Heidi
AU - Von Haken, Rebecca
AU - BAIL, Kasia
N1 - Funding Information:
The following co-authors have listed conflicts of interest: H.L. is funded by the NIA 1AGK23076662-02, serves as a board member and 2023 conference co-chair for the American Delirium Society, and serves as the web committee chair for the American Thoracic Society, Nursing Assembly. She has received royalties for keynote addresses at nursing conferences in 2022 and received a travel scholarship to attend the 2023 DECLARED conference in Sydney, Australia. G.C. is the President of the Australian Delirium Association. M.G. has received royalties for the edited books (Manual of ICU Procedures, Textbook of Ventilation Fluids, Electrolytes, and Blood Gases) from the publisher Jaypee Brothers Medical Publishers and has received financial support to attend the Annual Conference of Indian Society of Critical Care Medicine. G.H.C. has spoken on Humanization of Healthcare (Pfizer) and was supported by Pfizer to attend the COMMEC 2022 meeting. E.S.O. is supported by NIH/NIA funding (unrelated to this manuscript), received honoraria to present at the Edmund Beacham Annual Current Topics in Geriatrics, has patents issued or pending, and was the 2022 President of the American Delirium Society. M.O.C. received funding unrelated to this manuscript from Novo Fonden, Lundbeck Funden and Dagmar Marshells Fond. R.V.H received support from OrionPharma to attend meetings and/or travel.
Funding Information:
The \"WDAD Study Team\"comprises of 158 non-author collaborators.They are listed in Appendix 1a in the Supplementary Data.The authors would like to gratefully acknowledge the many participating clinicians for supporting the 2023 WDAD Study Team and survey.They are named in Appendix 1b in the Supplementary Data. The following co-authors have listed conflicts of interest: H.L. is funded by the NIA 1AGK23076662-02, serves as a board member and 2023 conference co-chair for the American Delirium Society, and serves as the web committee chair for the American Thoracic Society, Nursing Assembly. She has received royalties for keynote addresses at nursing conferences in 2022 and received a travel scholarship to attend the 2023 DECLARED conference in Sydney, Australia. G.C. is the President of the Australian Delirium Association. M.G. has received royalties for the edited books (Manual of ICU Procedures, Textbook of Ventilation Fluids, Electrolytes, and Blood Gases) from the publisher Jaypee Brothers Medical Publishers and has received financial support to attend the Annual Conference of Indian Society of Critical Care Medicine. G.H.C. has spoken on Humanization of Healthcare (Pfizer) and was supported by Pfizer to attend the COMMEC 2022 meeting. E.S.O. is supported by NIH/NIA funding (unrelated to this manuscript), received honoraria to present at the Edmund Beacham Annual Current Topics in Geriatrics, has patents issued or pending, and was the 2022 President of the American Delirium Society. M.O.C. received funding unrelated to this manuscript from Novo Fonden, Lundbeck Funden and Dagmar Marshells Fond. R.V.H received support from OrionPharma to attend meetings and/or travel.
Publisher Copyright:
© 2024 The Author(s). Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved.
PY - 2024/7/1
Y1 - 2024/7/1
N2 - Background: Delirium is a common complication of older people in hospitals, rehabilitation and long-term facilities. Objective: To assess the worldwide use of validated delirium assessment tools and the presence of delirium management protocols. Design: Secondary analysis of a worldwide one-day point prevalence study on World Delirium Awareness Day, 15 March 2023. Setting: Cross-sectional online survey including hospitals, rehabilitation and long-term facilities. Methods: Participating clinicians reported data on delirium, the presence of protocols, delirium assessments, delirium-awareness interventions, non-pharmacological and pharmacological interventions, and ward/unit-specific barriers. Results: Data from 44 countries, 1664 wards/units and 36 048 patients were analysed. Validated delirium assessments were used in 66.7% (n = 1110) of wards/units, 18.6% (n = 310) used personal judgement or no assessment, and 10% (n = 166) used other assessment methods. A delirium management protocol was reported in 66.8% (n = 1094) of wards/units. The presence of protocols for delirium management varied across continents, ranging from 21.6% (on 21/97 wards/units) in Africa to 90.4% (235/260) in Australia, similar to the use of validated delirium assessments with 29.6% (29/98) in Africa to 93.5% (116/124) in North America. Wards/units with a delirium management protocol [n = 1094/1664, 66.8%] were more likely to use a validated delirium test than those without a protocol [odds ratio 6.97 (95% confidence interval 5.289-9.185)]. The presence of a delirium protocol increased the chances for valid delirium assessment and, likely, evidence-based interventions. Conclusion: Wards/units that reported the presence of delirium management protocols had a higher probability of using validated delirium assessments tools to assess for delirium.
AB - Background: Delirium is a common complication of older people in hospitals, rehabilitation and long-term facilities. Objective: To assess the worldwide use of validated delirium assessment tools and the presence of delirium management protocols. Design: Secondary analysis of a worldwide one-day point prevalence study on World Delirium Awareness Day, 15 March 2023. Setting: Cross-sectional online survey including hospitals, rehabilitation and long-term facilities. Methods: Participating clinicians reported data on delirium, the presence of protocols, delirium assessments, delirium-awareness interventions, non-pharmacological and pharmacological interventions, and ward/unit-specific barriers. Results: Data from 44 countries, 1664 wards/units and 36 048 patients were analysed. Validated delirium assessments were used in 66.7% (n = 1110) of wards/units, 18.6% (n = 310) used personal judgement or no assessment, and 10% (n = 166) used other assessment methods. A delirium management protocol was reported in 66.8% (n = 1094) of wards/units. The presence of protocols for delirium management varied across continents, ranging from 21.6% (on 21/97 wards/units) in Africa to 90.4% (235/260) in Australia, similar to the use of validated delirium assessments with 29.6% (29/98) in Africa to 93.5% (116/124) in North America. Wards/units with a delirium management protocol [n = 1094/1664, 66.8%] were more likely to use a validated delirium test than those without a protocol [odds ratio 6.97 (95% confidence interval 5.289-9.185)]. The presence of a delirium protocol increased the chances for valid delirium assessment and, likely, evidence-based interventions. Conclusion: Wards/units that reported the presence of delirium management protocols had a higher probability of using validated delirium assessments tools to assess for delirium.
KW - assessments
KW - delirium
KW - encephalopathy
KW - older people
KW - patient safety
KW - protocols
KW - quality improvement
UR - https://www.scopus.com/pages/publications/85197676110
UR - https://pubmed.ncbi.nlm.nih.gov/39189681/
U2 - 10.1093/ageing/afae129
DO - 10.1093/ageing/afae129
M3 - Article
C2 - 38952186
AN - SCOPUS:85197676110
SN - 0002-0729
VL - 53
SP - 1
EP - 9
JO - Age and Ageing
JF - Age and Ageing
IS - 7
ER -